Effects of pramlintide (amylin agonist) in type 1 diabetes are not mediated by GLP-1 (7-36)amide

被引：0
|
作者：
Gutniak, MK
Svartberg, J
Petrella, E
Adner, N
机构：
来源：
DIABETES | 2000年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
442
引用
收藏
页码：A109 / A110
页数：2
相关论文
共 50 条
  • [41] Stimulation of pulsatile secretion of insulin and GLP-1(7-36)amide following by oral glucose
    Balks, HJ
    Holst, JJ
    Brabant, G
    VonzurMuhlen, A
    DIABETOLOGIA, 1997, 40 : 495 - 495
  • [42] LONG-TERM ADMINISTRATION OF GLP-1(7-36)AMIDE TO NORMAL AND NIDDM RATS
    KAWAI, K
    OHASHI, S
    WATANABE, Y
    YOKOTA, C
    SUZUKI, S
    YAMASHITA, K
    DIABETOLOGIA, 1993, 36 : A47 - A47
  • [43] PRESENCE OF GLUCAGON AND GLP-1(7-36)AMIDE SPECIFIC RECEPTORS IN HUMAN FAT MEMBRANES
    MERIDA, E
    DELGADO, E
    MOLINA, LM
    VILLANUEVAPENACARRILLO, ML
    VALVERDE, I
    DIABETOLOGIA, 1992, 35 : A76 - A76
  • [44] POTENT GLYCOGENIC EFFECT OF GLP-1(7-36)AMIDE IN RAT SKELETAL-MUSCLE
    VILLANUEVAPENACARRILLO, ML
    ALCANTARA, AI
    CLEMENTE, F
    DELGADO, E
    VALVERDE, I
    DIABETOLOGIA, 1994, 37 (11) : 1163 - 1166
  • [45] GLIP (GLP-1(7-36)amide) tablet lowers blood glucose in humans.
    Ahren, B
    Larsson, H
    Heiber, S
    Juneskans, O
    Holst, JJ
    Gutniak, MK
    DIABETES, 1996, 45 : 96 - 96
  • [46] Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in Type 2 diabetic patients
    Nauck, MA
    Weber, I
    Bach, I
    Richter, S
    Orskov, C
    Holst, JJ
    Schmiegel, W
    DIABETIC MEDICINE, 1998, 15 (11) : 937 - 945
  • [47] BINDING OF GLP-1(7-36)AMIDE ANALOGS AND GLP-1/GIP HYBRID PEPTIDES TO RINM5F INSULINOMA CELLS
    GALLWITZ, B
    WITT, M
    SCHMIDT, WE
    DIGESTION, 1993, 54 (06) : 345 - 345
  • [48] Regulation of antro-pyloro-duodenal and fundic motility by GLP-1 (7-36)amide (GLP-1): Involvement of cholinergic pathways.
    Schirra, J
    Nicolaus, M
    Craney, C
    Arnold, R
    Goeke, B
    Katschinski, M
    GASTROENTEROLOGY, 2001, 120 (05) : A73 - A74
  • [49] Endogenous GLP-1(7-36)amid (GLP-1):: Intestinal release and endocrine action in human
    Schirra, J
    Nicolaus, M
    Woerle, HJ
    Göke, B
    REGULATORY PEPTIDES, 2004, 122 (01) : 37 - 37
  • [50] PRESERVED INCRETIN ACTIVITY OF GLP-1 [7-36 AMIDE] BUT NOT OF SYNTHETIC HUMAN GIP IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS
    NAUCK, MA
    HEIMESAAT, MM
    ORSKOV, C
    HOLST, JJ
    EBERT, R
    CREUTZFELDT, W
    DIABETOLOGIA, 1992, 35 : A39 - A39
12345